The (https://www.sec.gov/Archives/edgar/data/1082554/000123158926000017/xslF345X06/primarydocument.xml) in biotech is the signal everyone's missing while fixating on jobs data. UTHR's GC just dumped $4.1M in stock over two days — Paul Mahon sold 5,532 shares across four tranches at $512–$517. That's not "rebalancing." That's "the stock peaked and insiders know it." When executives sell this heavily into strength, it's a 6-12 month bearish flag.

Research these companies